In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI

Blood. 2017 Jun 29;129(26):3495-3498. doi: 10.1182/blood-2017-03-772285. Epub 2017 Apr 26.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Biomarkers
  • Chromosome Aberrations
  • Comorbidity
  • Creatinine / blood*
  • Female
  • Follow-Up Studies
  • Genes, p53
  • Humans
  • Immunoglobulin Heavy Chains / genetics
  • Kaplan-Meier Estimate
  • Karyotyping
  • Leukemia, Lymphocytic, Chronic, B-Cell / mortality*
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Severity of Illness Index*
  • beta 2-Microglobulin / analysis

Substances

  • Biomarkers
  • Immunoglobulin Heavy Chains
  • beta 2-Microglobulin
  • Creatinine